Pages

Monday, August 4, 2014

Final Patient Treated In NeuralStem Inc. Phase II Als Stem Cell Trial

The multicenter Phase II trial treated 15 ambulatory patients in five different dosing cohorts.

http://ift.tt/1nkHqe4

No comments:

Post a Comment